LORD, ABBETT & CO. LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 68 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2017$2,625,000
-37.6%
66,702
-50.8%
0.01%
-41.7%
Q3 2017$4,207,000
-70.4%
135,511
-73.9%
0.01%
-71.4%
Q2 2017$14,212,000
-28.6%
519,622
-3.8%
0.04%
-30.0%
Q1 2017$19,897,000
+192.1%
539,944
+234.2%
0.06%
+185.7%
Q3 2015$6,812,000161,5770.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 460,000$14,872,00013.19%
VHCP Management II, LLC 141,611$4,578,0003.76%
Perceptive Advisors 1,186,630$38,363,0002.84%
RTW INVESTMENTS, LP 175,156$5,663,0001.87%
Casdin Capital, LLC 65,000$2,101,0001.86%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,163,811$37,626,0001.52%
RA Capital Management 457,142$14,779,0001.46%
VHCP Management, LLC 60,691$1,962,0001.19%
Iguana Healthcare Management, LLC 110,000$3,556,0001.17%
Partner Investment Management, L.P. 15,634$505,0000.83%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders